Eylea

Regeneron Reports Mixed Q3 Sales as Eylea Franchise Remains Under Pressure
BioSpace
Fri, 11/1/24 - 10:54 am
Regeneron
Eylea
earnings
Regeneron loses bid to block Amgen's Eylea biosimilar launch in US
Reuters
Tue, 10/22/24 - 11:30 pm
Regeneron
Amgen
biosimilars
Eylea
Regeneron's stock drops as it loses bid to block Amgen's Eylea biosimilar
Fierce Pharma
Tue, 09/24/24 - 11:56 am
Regeneron
Amgen
legal
biosimilars
Eylea
FDA approves two biosimilars to blockbuster eye drug Eylea
Reuters
Mon, 05/20/24 - 11:23 am
Regeneron
Eylea
FDA
biosimilars
Biocon Biologics
Yesafli
Opuviz
Samsung BioLogics
Biogen
Regeneron Misses Q1 Earnings on Lower-Than-Expected Eylea Sales
BioSpace
Thu, 05/2/24 - 10:10 pm
Regeneron
Eylea
earnings
Regeneron's blockbuster eye drug posts weaker sales due to inventory impact
Reuters
Thu, 05/2/24 - 11:26 am
Regeneron
earnings
Eylea
Regeneron to defend against DOJ complaint on drug-price manipulation
Yahoo/Reuters
Tue, 04/16/24 - 10:02 pm
Regeneron
DOJ
drug pricing
Eylea
DOJ Sues Regeneron for Allegedly Inflating Medicare Pricing for Eye Drug Eylea
BioSpace
Thu, 04/11/24 - 11:27 am
DOJ
Regeneron
Medicare
Eylea
drug pricing
False Claims Act
Innovent's anti-VEGF drug matches Eylea in phase 2 eye disease trial
Fierce Biotech
Tue, 03/19/24 - 11:21 am
Innovent
Regeneron
Bayer
anti-VEGF
neovascular age-related macular degeneration
IBI302
Eylea
US appeals court revives Regeneron's antitrust lawsuit against Novartis
Yahoo/Reuters
Mon, 03/18/24 - 05:09 pm
Novartis
Regeneron
legal
Eylea
Lucentis
antitrust
4DMT gene therapy cuts need for Eylea in wet AMD trial
Pharmaphorum
Mon, 02/5/24 - 10:09 am
4D Molecular Therapeutics
wet age-related macular degeneration
clinical trials
gene therapy
Eylea
13 Therapies Make Clarivate’s 2024 Drugs to Watch List
BioSpace
Wed, 01/10/24 - 06:30 pm
Clarivate
Eylea
Tarpeyo/Kinpeygo
Dato-DXd
Altuviiio
RPL554
exa-cel
lovo-cel
LY-3074828
Akeega
Abrysvo
Talvey
Arexvy
IMAB362
JPM24, Day 1: Regeneron's Eylea misses analyst estimates; Moderna touts $6.7B in '23 sales
Fierce Pharma
Mon, 01/8/24 - 11:45 am
JPMHC 2024
Regeneron
Eylea
Eylea HD
Moderna Therapeutics
Regeneron Gains After Eye-Drug Patent Victory Over Viatris
Yahoo/Bloomberg
Sun, 12/31/23 - 11:46 am
Regeneron
Eylea
Viatris
patents
legal
EyePoint Pharma Stock Surges on Phase II Wet AMD-Therapy Results
BioSpace
Mon, 12/4/23 - 06:12 pm
Eyepoint
clinical trials
wet age-related macular degeneration
Eylea
EYP-1901
European regulator endorses high-dose version of Bayer eye drug Eylea
Reuters
Fri, 11/10/23 - 10:09 am
Bayer
EMA
Eylea
Roche
Regeneron touts launch of high-dose Eylea in battle with Roche's Vabysmo
Fierce Pharma
Thu, 11/2/23 - 11:48 am
Regeneron
Eylea
Roche
Vabysmo
Could This Biosimilar Drug Be Novartis' Next Blockbuster?
Motley Fool
Tue, 09/5/23 - 08:39 pm
Novartis
biosimilars
Eylea
Regeneron Expands Eylea’s Label with High-Dose Approval
BioSpace
Mon, 08/21/23 - 10:44 am
Regeneron
Eylea
FDA
Sandoz plans to enter the Eylea biosimilar race
Clinical Trials Arena
Tue, 08/15/23 - 10:03 am
Sandoz
generics
biosimilars
Eylea
Novartis
wet age-related macular degeneration

Pages